Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of Medicine

Hum Gene Ther. 1993 Feb;4(1):71-85. doi: 10.1089/hum.1993.4.1-71.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers*
  • Blood Cells / cytology
  • Blood Transfusion*
  • Bone Marrow Cells
  • Bone Marrow Transplantation*
  • Clinical Protocols
  • Hematopoiesis
  • Hematopoietic Stem Cells / cytology
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Middle Aged
  • Retroviridae*
  • Transplantation, Autologous

Substances

  • Biomarkers